Heel Luffa Comp Nasal Spray 20ml (known as Luffeel)
Allergies cause a great deal of suffering and inconvenience to those affected. Up to 20% of the population suffers from allergies. Allergic reactions occur when a trigger, such as pollen or dust, induce an exaggerated response by the immune system. While avoidance of triggers makes sense it is not always possible. A better option is to try to stabilise the immune response.
No side effects
Does not cause drowsiness
Suitable for long term use
Significant symptom relief
In a drug monitoring study, concomitant administration of Luffa comp.-Heel nasal spray was rated by over 70% of 1,090 hay fever patients as either "good" or "very good" therapy.
In a randomized, double-blind clinical study of 146 patients suffering from seasonal allergic rhinits the effectiveness of Luffa comp.-Heel nasal spray was compared to that of cromolyn sodium nasal spray over a six week period.
Four to eight sprays daily per nostril of Luffa comp.-Heel nasal spray resulted in significant and lasting symptom improvement, equivalent to that of cromolyn sodium. Both medications were well tolerated.
Instructions for use:
In cases of known seasonal allergies, Luffa comp. can be used in advance of the expected symptoms.
For adults and children over 6 years:
2 sprays into each nostril 3-4 times daily.
In acute conditions:
2 sprays into each nostril every ½ to 1 hour, but not more than 12 times daily.
For children 6months to 6 years:
1 spray into each nostril 3 times daily.
In acute conditions:
1 spray into each nostril every ½ to 1 hour, but not more than 12 times daily.
Ingredients: Each spray contains: 1 g cont. Luffa operculata 4x, Luffa operculata 12x, Luffa operculata 30x 100 mg each, Galphimia glauca 4x, Galphimia glauca 12x, Galphimia glauca 30x 10 mg each; Histaminum 12x, Histaminum 30x, Histaminum 200x, 50mg each, Sulfur 12x, Sulfur 30x, Sulfur 200x 50mg each. Contains sodium chloride
A Randomised Equivalence Trial Comparing the Efficacy and Safety of Luffa comp.-Heel Nasal Spray with Cromolyn Sodium Spray in the Treatment of Seasonal Allergic Rhinitis
M Weiser, LH Gegenheimer, P Klein. Research In Complementary Medicine, Vol. 6, No. 3, 1999, pp 142-148.
146 outpatients with symptoms of hay fever were enrolled in a 42 day randomised, double-blind, equivalence trial. The patient’s received 0.14mL of Luffa-comp. -Heel Nasal Spray four times daily. The results of the study demonstrate a quick and lasting effect, which was independent from the medication applied and produced a nearly complete remission from the hay fever symptoms. Adverse systemic effects did not occur.
The study proved that for the treatment of hay fever, Luffa comp. is as efficient and well tolerated as conventional therapy.